Cite
Magavern EF, Kaski JC, Turner RM, et al. The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. Eur Heart J Cardiovasc Pharmacother. 2022;8(1):85-99doi: 10.1093/ehjcvp/pvab018.
Magavern, E. F., Kaski, J. C., Turner, R. M., Drexel, H., Janmohamed, A., Scourfield, A., Burrage, D., Floyd, C. N., Adeyeye, E., Tamargo, J., Lewis, B. S., Kjeldsen, K. P., Niessner, A., Wassmann, S., Sulzgruber, P., Borry, P., Agewall, S., Semb, A. G., Savarese, G., Pirmohamed, M., & Caulfield, M. J. (2022). The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. European heart journal. Cardiovascular pharmacotherapy, 8(1), 85-99. https://doi.org/10.1093/ehjcvp/pvab018
Magavern, Emma Forton, et al. "The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy." European heart journal. Cardiovascular pharmacotherapy vol. 8,1 (2022): 85-99. doi: https://doi.org/10.1093/ehjcvp/pvab018
Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ. The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. Eur Heart J Cardiovasc Pharmacother. 2022 Jan 05;8(1):85-99. doi: 10.1093/ehjcvp/pvab018. PMID: 33638977.
Copy
Download .nbib